to compare the time duration of pain relief by adding injection dexmedetomidine and injection butorphanol in erector spinae plane block in children 1 year to 18 years posted for chest and abdominal surgeries

A comparative study of dexmedetomidine and butorphanol as an adjuvant in ultrasound-guided erector spinae plane block for perioperative analgesia in children undergoing thoracoabdominal surgeries - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/075620

Enrollment

Registered

2024-10-22

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Q10-Q18- Congenital malformations of eye, ear, face and neck Health Condition 2: Q20-Q28- Congenital malformations of the circulatory system Health Condition 3: Q60-Q64- Congenital malformations of the urinary system Health Condition 4: Q30-Q34- Congenital malformations of the respiratory system Health Condition 5: Q65-Q79- Congenital malformations and deformations of the musculoskeletal system Health Condition 6: J90-J94- Other diseases of the pleura Health Condition 7: I70-

Interventions

Intervention1: Erector spinae plane block with adjuvant injection dexmedetomidine: Erector spinae plane block is given ultrasound guided, in group A-drug will be given 0.125% bupivacaine 0.5ml/kg with

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age: 1 year - 18 years 2. ASA I and II patients of either sex 3. Elective thoracic and abdominal surgery.

Exclusion criteria

Exclusion criteria: 1. Evidence of coagulopathy or thrombocytopenia 2. History of bleeding or clotting disorders 3. Local infection 4. Allergy to drugs used in study 5. Intellectual disability 6. Chronic pain disorder 7. On chemotherapy

Design outcomes

Primary

Measure	Time frame
duration of analgesia i.e. time of block placement to the time of administration of first rescue analgesiaTimepoint: upto 24 HOURS	—

Secondary

Measure	Time frame
1. Pain score at predefined time points following surgery for upto 24 hours Timepoint: POSTOPERATIVELY - ON ARRIVAL, at 15 minutes, 30 minutes, 60 minutes, 90 minutes and 120 minutes, 4 hourly up to 24 hours;haemodynamic stabilityTimepoint: intraoperatively - every 15mins post operatively - at 15mins, 30 ,60,90,120 minutes, 4hourly upto 24 hours	—

Countries

India

Contacts

Public ContactDr Mukul Jain

POSTGRADUATE INSTITUTE OF CHILD HEALTH

jainmukul2004@yahoo.com9971588623

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026